(Q33581949)

English

Reassessing the relevance of pharmacoeconomic analyses in formulary decisions

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

Reassessing the relevance of pharmacoeconomic analyses in formulary decisions (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Johnson JA

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Friesen E

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

479-485

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Rating the quality of evidence for clinical practice guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On squeezing balloons. Cost control fails again

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canada's new guidelines for the economic evaluation of pharmaceuticals

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity analysis in economic evaluation: a review of published studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacy and Therapeutics committee. Cost-containment considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease management programs

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic analysis in formulary decisions: an international perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The practical impact of pharmacoeconomics on institutional managers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The formulary decision-making process in a US academic medical centre

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The generalisability of pharmacoeconomic studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The FDA just says yes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10180747

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199813050-00001

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33581949&oldid=2195520648"